CBDNewsBreaks – Cannabis Global Inc. (CBGL) Announces Research Partnership to Develop Cannabinoid Infusion Techniques

Company: Cannabis Global Inc. (CBGL)
Category: News

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, has formed a key research relationship with Marijuana Company of America Inc. (OTC: MCOA). MCOA joins the Project Varin research and development program, along with already existing partner Natural Plant Extract of California Inc. (“NPE”). The companies are collaborating on the development of new protocols and techniques for food and beverage cannabinoid infusion. Recently the program has created highly loaded cannabinoid nano units made from all-natural ingredients. These nano units will allow product formulators to create foods and beverages with clean labels and without bitter tastes. This new approach also allows manufacturers to use fewer active ingredients, which may reduce costs, or utilize the full amount of an active ingredient to obtain a superior effect. “Marijuana Company of America and Cannabis Global are both equity holders in NPE, which holds both manufacturing and distribution licenses within the State of California, so this collaboration between the three companies is a natural fit,” said Cannabis Global CEO Arman Tabatabaei in the press release. “Upon the filing of our next patent in this area, we plan to jointly work within the California regulatory framework to create a new method to infuse food and beverages with THC. The technology holds the promise to rewrite the industry dynamic relative to both cost of infusion and overall efficacy for not only THC, but also for other cannabinoids.”

To view the full press release, visit https://cnw.fm/vlfhU

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at http://cnw.fm/CBGL

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722